INS and Hypoglycemia: Compared with insulin alone, dapagliflozin 5 and 10 mg did not increase the incidence of severe hypoglycemia (OR = 1.1, 95% CI: 0.86 to 1.4 and OR = 1, 95% CI: 0.79 to 1.3).